Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Levels of PTEN protein modulate Akt phosphorylation on serine 473, but not on threonine 308, in IGF-II-overexpressing rhabdomyosarcomas cells

Abstract

Constitutive activation of Akt has been found in many types of human cancer, and is believed to promote proliferation and increased cell survival thereby contributing to cancer progression. In this study, we examined Akt phosphorylation on Ser473 and Thr308 in seven IGF-II-overexpressing rhabdomyosarcomas (RMS) cells. All the RMS cell lines tested had high levels of Akt phosphorylation on Thr308, whereas three cell lines (Rh5, Rh18, and CTR) had a much lower level of Akt phosphorylation on Ser473. To determine whether the difference in Akt phosphorylation on Ser473, but not on Thr308, observed among cell lines is a cell-specific phenomenon or due to other factors, which possibly downregulate Akt phosphorylation, we examined expression of PTEN protein, which acts as a negative regulator of the PI3K/Akt signaling pathway through its ability to dephosphorylate phosphatidylinositol 3,4,5-triphosphate (PIP3). The levels of PTEN expression inversely correlate with Akt phosphorylation on Ser473, but not on Thr308. Consistent with this finding, transfection of wild-type PTEN into RMS and mouse myoblast C2C12 cells resulted in reduced Akt phosphorylation on Ser473, but not on Thr308. Our data suggest that Ser473 may be a key target residue for PTEN to modulate the effects of IGF-II on activating the PI3K/Akt pathway in RMS cells. A better understanding of the pathway in RMS will likely contribute to insights into the biology of the RMS tumorigenesis and hopefully lead to novel therapeutic options.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P and Hemmings BA . (1996). EMBO J., 15, 6541–6551.

  • Alessi DR and Cohen P . (1998). Curr. Opin. Genet. Dev., 8, 55–62.

  • Bellacosa A, de Feo D, Godwin AK, Bell DW, Cheng JQ, Altomare DA, Wan M, Dubeau L, Scambia G and Masciullo V, et al. 1995. Int. J. Cancer, 64, 280–285.

  • Brazil DP and Hemmings BA . (2001). Trends Biochem. Sci., 26, 657–664.

  • Brodbeck D, Hill MM and Hemmings BA . (2001). J. Biol. Chem., 276, 29550–29558.

  • Cheng JQ, Godwin AK, Bellacosa A, Taguchi T, Franke TF, Hamilton TC, Tsichlis PN and Testa JR . (1992). Proc. Natl. Acad. Sci. USA, 89, 9267–9271.

  • Cheng JQ, Ruggeri B, Klein WM, Sonoda G, Altomare DA, Watson DK and Testa JR . (1996). Proc. Natl. Acad. Sci. USA, 93, 3636–3641.

  • Cross DA, Alessi DR, Cohen P, Andjelkovich M and Hemmings BA . (1995). Nature, 378, 785–789.

  • Davies MA, Lu Y, Sano T, Fang X, Tang P, LaPushin R, Koul D, Bookstein R, Stokoe D, Yung WK, Mills GB and Steck PA . (1998). Cancer Res., 58, 5285–5290.

  • Delcommenne M, Tan C, Gray V, Rue L, Woodgett J and Dedhar S . (1998). Proc. Natl. Acad. Sci. USA, 95, 11211–11216.

  • Downward J . (1998). Curr. Opin. Cell. Biol., 10, 262–267.

  • El-Badry OM, Helman LJ, Chatten J, Steinberg SM, Evans AE and Israel MA . (1991). J. Clin. Invest., 87, 648–657.

  • Franke TF, Kaplan DR, Cantley LC and Toker A . (1997). Science, 275, 665–668.

  • Furnari FB, Lin H, Huang HS and Cavenee WK . (1997). Proc. Natl. Acad. Sci. USA, 94, 12479–12484.

  • Ghosh AK, Grigorieva I, Steele R, Hoover RG and Bay RB . (1999). Gene, 235, 85–91.

  • Gimm O, Perren A, Weng LP, Marsh DJ, Yeh JJ, Ziebold U, Gil E, Hinze R, Delbridge L, Lees JA, Mutter GL, Robinson BG, Komminoth P, Dralle and Eng C . (2000). Am. J. Pathol., 156, 1693–1700.

  • Haas-Kogan D, Shalev N, Wong M, Mills G, Yount G and Stokoe D . (1998). Curr. Biol., 8, 1195–1198.

  • Hemmings BA . (1997a). Science, 275, 628–630.

  • Hemmings BA . (1997b). Science, 277, 534.

  • Hill MM and Hemmings BA . (2002). Pharmacol. Ther., 93, 243–251.

  • Kroner C, Eybrechts K and Akkerman JW . (2000). J. Biol. Chem., 275, 27790–27822.

  • Lachyankar MB, Sultana N, Schonhoff CM, Mitra P, Poluha W, Lambert S, Quesenberry PJ, Litofsky NS, Recht LD, Nabi R, Miller SJ, Ohta S, Neel BG and Ross AH . (2000). J. Neurosci., 20, 1404–1413.

  • Leslie NR and Downes CP . (2002). Cell. Signall., 14, 285–295.

  • Li J, Simpson L, Takahashi M, Miliaresis C, Myers MP, Tonks N and Parsons R . (1998). Cancer Res., 58, 5667–5672.

  • Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH and Parsons R . (1997). Science, 275, 1943–1947.

  • Lynch DK, Ellis CA, Edwards PA and Hiles ID . (1999). Oncogene, 18, 8024–8032.

  • Maehama T and Dixon JE . (1998). J. Biol. Chem., 273, 13375–13378.

  • Medema RH, Kops GJ, Bos JL and Burgering BM . (2000). Nature, 404, 782–787.

  • Nakatani K, Thompson DA, Barthel A, Sakaue H, Liu W, Weigel RJ and Roth RA . (1999). J. Biol. Chem., 274, 21528–21532.

  • Nicholson KM and Anderson NG . (2002). Cell. Signall., 14, 381–395.

  • Persad S, Attwell S, Gray V, Mawji N, Deng JT, Leung D, Yan J, Sanghera J, Walsh MP and Dedhar S . (2001a). J. Biol. Chem., 276, 27462–27465.

  • Persad S, Troussard AA, McPhee TR, Mulholland DJ and Dedhar S . (2001b). J. Cell. Biol., 153, 1161–1174.

  • Ramaswamy S, Nakamura N, Vazquez F, Batt DB, Perera S, Roberts TM and Sellers WR . (1999). Proc. Natl. Acad. Sci. USA, 96, 2110–2115.

  • Reeve AE, Eccles MR, Wilkins RJ, Bell GI and Millow LJ . (1985). Nature, 317, 258–260.

  • Scheid MP and Woodgett JR . (2001). Nature, 2, 760–768.

  • Schubert KM, Scheid MP and Duronio V . (2000). J. Biol. Chem., 275, 13330–13335.

  • Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP and Mak TW . (1998). Cell, 95, 29–39.

  • Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH and Tavtigian SV . (1997). Nat. Genet., 15, 356–362.

  • Stephens L, Anderson K, Stokoe D, Erdjument-Bromage H, Painter GF, Holmes AB, Gaffney PR, Reese CB, McCormick F, Tempst P, Coadwell J and Hawkins PT . (1998). Science, 279, 710–714.

  • Stewart CE and Rotwein P . (1996). Physiol. Rev., 76, 1005–1026.

  • Stokoe D, Stephens LR, Copeland T, Gaffney PR, Reese CB, Painter GF, Holmes AB, McCormick F and Hawkins PT . (1997). Science, 277, 567–570.

  • Sun H, Lesche R, Li DM, Liliental J, Zhang H, Gao J, Gavrilova N, Mueller B, Liu X and Wu H . (1999). Proc. Natl. Acad. Sci. USA, 96, 6199–6204.

  • Takahashi-Tezuka M, Yoshida Y, Fukada T, Ohtani T, Yamanaka Y, Nishida K, Nakajima K, Hibi M and Hirano T . (1998). Mol. Cell. Biol., 18, 4109–4117.

  • Tamura M, Gu J, Matsumoto K, Aota S, Parsons R and Yamada KM . (1998). Science, 280, 1614–1617.

  • Toker A and Newton AC . (2000). J. Biol. Chem., 275, 8271–8274.

  • Toretsky JA and Helman LJ . (1996). J. Endocrinol., 149, 367–372.

  • Tsatsanis C and Spandidos DA . (2000). Int. J. Mol. Med., 5, 583–590.

  • Ullrich A, Gray A, Tam AW, Yang-Fen T, Tsubokawa M, Collins C, Henzel W, Le Bon T, Kathuria S, Chen E, Jacobs S, Prancke U, Ramachandran J and Fyjita-Yamaguchi Y . (1986). EMBO J., 5, 2503–2512.

  • Wan X and Helman LJ . (2002). Neoplasia, 4, 400–408.

  • Weng LP, SmithWM, Brown JL and Eng C . (2001). Hum. Mol. Genet., 10, 605–616.

  • Wick W, Furnari FB, Naumann U, Cavenee WK and Weller M . (1999). Oncogene, 18, 3936–3943.

  • Williams MR, Arthur JS, Balendran A, van der Kaay J, Poli V, Cohen P and Alessi DR . (2000). Curr. Biol., 10, 439–448.

  • Yuan ZQ, Sun M, Feldman RI, Wang G, Ma X, Jiang C, Coppola D, Nicosia SV and Cheng JQ . (2000). Oncogene, 19, 2324–2330.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lee J Helman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wan, X., Helman, L. Levels of PTEN protein modulate Akt phosphorylation on serine 473, but not on threonine 308, in IGF-II-overexpressing rhabdomyosarcomas cells. Oncogene 22, 8205–8211 (2003). https://doi.org/10.1038/sj.onc.1206878

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206878

Keywords

This article is cited by

Search

Quick links